Long-term follow up after heart transplantation - A survey among German heart transplant centers;Langzeitbetreuung nach herztransplantation - Eine bestandsaufnahme

Zeitschrift fur Kardiologie

Volumn 89, Issue 2, 2000, Pages 93-99

  Pethig, K ^a   Dengler, T J ^d   Mohacsi, P ^b   Deng, M C ^c   Wahlers, Th ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d NONE

Author keywords

Cardiac allograft vasculopathy; Heart transplantation; Immunosuppression; Long term follow up; Malignancy

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARTICLE; FEMALE; FOLLOW UP; GERMANY; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL SOCIETY; POSTOPERATIVE COMPLICATION; VASCULAR DISEASE;

AFTERCARE; CAUSE OF DEATH; FOLLOW-UP STUDIES; GERMANY; HEART TRANSPLANTATION; HUMANS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SURVIVAL RATE;

EID: 0034063537     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920050015     Document Type: Article

References (33)

1. 1. Robbins RC, Barlow CW, Oyer PE, Hunt SA, Miller JL, Reitz BA, Stinson EB, Shumway NE (1999) Thirty years of cardiac transplantation at Stanford University. J Thorac Cardiovasc Surg 117:939-951
2. 2. Barnard CN (1967) The operation. S African Med J 41:1271
3. 3. Hosenpud JD, Bennett LE, Keck BM, Fiol B, Boucek MM, Novick R (1998) The registry of the International Society for Heart and Lung Transplantation: fifteenth official report 1998: J Heart Lung Transpl 17:656-668
4. 4. Fraund S, Pethig K, Franke U, Wahlers T, Harringer W, Cremer J, Fieguth HG, Oppelt P, Haverich A (1999) 10-year survival after heart transplantation - palliative procedure or successful long-term therapy? Heart 82:47-51
5. 5. Angermann CE, Beyersdorf F, Deng MC, Dengler TJ, Geiger A, Haaf B, Haverich A, Hummel M, Mohacsi P, Permanetter B, Pethig K, Scheidt W, Wahlers T, Weis M, Welz A, Zerkowski HR, Zimmermann R (1996) Indikationen, Kontraindikationen und differentialtherapeutische Alternativen der Herztransplantation. Z Kardiol 85: 519-527
6. 6. Beyersdorf F, Costard-Jäckle A, Deng M, Dengler TJ, Fuhrmann B, Hardmann B, Haverich A, Hoberg E, Hummel M, Körner MM, Meiser B, Permanetter B, Rödiger W, Schäfers HJ, Wahlers T, Weis M, Zerkowski HR, Zimmermann R (1996) Herztransplantation: Nachsorge und Rehabilitation. Derzeitiger Stand und Ergebnisse einer Umfrage bei den deutschen Transplantationsprogrammen. Z Kardiol 85:67-77
7. 7. Weis M, Scheidt W (1997) Cardiac allograft vasculopathy. A review. Circulation 96:2069-2077
8. 8. Gallo P, Agozzino L, Angelini A, Arbustini E, Bartoloni P, Bonacina E, Bosman C, Catani G, Di Gioia C, Giordana C, Leone O, Motta T, Pucci A, Rocco M (1997) Causes of late failure after heart transplantation: a ten year survey. J Heart Lung Transpl 16:1113-1121
9. 9. Pethig K, Fischer H, Wahlers T, Harringer W, Oppelt P, Haverich A ( 1997) Todesursachen nach Herztransplantation: Einfluß auf die klinische Langzeitbetreuung. Z Kardiol 86 (S3):98 (Abstrakt)
10. 10. Oyer PE, Stinson EB, Jamieson SW, Hunt SA, Billingham ME, Scott W, Bieber CP, Reitz BA, Shumway NE (1983) Cyclosporin-A in cardiac allografting: a preliminary experience. Transplant Proc 15:1247-1252
11. 11. Kirklin JK, Naftel DC, Bourge RC, White Williams C, Caulfield JB, Tarkka MR, Holman WL, Zorn GL (1992) Rejection after cardiac transplantation. A time-related risk factor analysis. Circulation 86:II236-41
12. 12. White JA, Guiraudon C, Pflugfelder PW, Kostuk WJ (1995) Routine surveillance myocardial biopsies are unnecessary beyond one year after heart transplantation. J Heart Lung Transplant 14:1052-1056
13. 13. Valantine HA, Yeoh TK, Gibbons R, McCarthy P, Stinson EB, Billingham ME, Popp RL (1991) Sensitivity and specificity of diastolic indexes for rejection surveillance: temporal correlation with endomyocardial biopsy. J Heart Lung Transpl 10: 757-765
14. 14. Angermann CE, Nassau K, Stempfle HU, Kruger TM, Drewello R, Junge R, Überfuhr P, Weiss M, Theisen K (1997) Recognition of acute cardiac allograft rejection from serial integrated backseatter analysis in human orthotopic heart transplant recipients. Comparison with conventional echocardiography. Circulation 95:140-150
15. 15. Fishman JA, Rubin RH (1998) Infection in organ transplant recipients. N Engl J Med 338:1741-1751
16. 16. Smart FW, Naftel DC, Costanzo MR, Levine TB, Pelletier GB, Yancy CW, Hobbs RE, Kirklin JK, Bourge RC (1996) Risk factors for early, cumulative, and fatal infections after heart transplantation: a multiinstitutional study. J Heart Lung Transplant 15:329-341
17. 17. Miller LW, Naftel DC, Bourge RC, Kirklin JK, Brozena SC, Jarcho J, Hobbs RE, Mills RM (1994) Infection after heart transplantation: a multiinstitutional study. J Heart Lung Transplant 13:381-393
18. 18. Johnson DE, Gao SZ, Schroeder JS, De-Campli WM, Billingham ME (1989) The spectrum of coronary artery pathologic findings in human cardiac allografts. J Heart Transplant 8:349-359
19. 19. Penn I (1993) Incidence and treatment of neoplasia after transplantation. J Heart Lung Transplant 12:S328-S336
20. 20. St Goar FG, Pinto FJ, Alderman EL, Valantine HA, Schroeder JS, Gao SZ, Stinson EB, Popp RL (1992) Intracoronary ultrasound in cardiac transplant recipients. In vivo evidence of "angiographically silent" intimal thickening (see comments). Circulation 85:979-987
21. 21. Rickenbacher PR, Pinto FJ, Chenzbraun A, Botas J, Lewis NP, Alderman EL, Valantine HA, Hunt Sa, Schroeder JS, Popp RL, Yeung AC (1995) Incidence and severity of transplant coronary artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound. J Am Coll Cardiol 25:171-177
22. 22. Pethig K, Besser K, Heublein B, Wahlers T, Harringer W, Haverich A (1999) Koronare Vaskulopathie nach Herztransplantation - Einfluß von zeitlichem Auftreten, Schweregrad und Progredienz auf die Prognose im Langzeitverlauf. Z Kardiol 88: 498-506
23. 23. Rickenbacher PR, Pinto FJ, Lewis NP, Hunt SA, Alderman EL, Schroeder JS, Stinson EB, Brown BW, Valantine HA (1995) Prognostic importance of intimal thickness as measured by intracoronary ultrasound after cardiac transplantation. Circulation 92:3445-3452
24. 24. Spes C, Mudra H, Schnaack SD, Klauss V, Reichle FM, Überfuhr P, Theisen K, Angermann CE (1996) Dobutamine stress echocardiography for noninvasive diagnosis of cardiac allograft vasculopathy: a comparison with angiography and intravascular ultrasound. Am J Cardiol 78:168-174
25. 25. Gao AZ, Alderman EL, Schroeder JS, Silverman JF, Hunt SA (1988) Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cardiol 12:334-340
26. 26. Pethig K, Heublein B, Maass C, Wahlers T, Haverich A (1997) Stellenwert des intravaskulären Ultraschalls in Diagnostik und Quantifizierung der Transplantatvaskulopathie.Tx Med 9:33-37
27. 27. Heublein B, Pethig K, Maaß CH, Wahlers T, Haverich A (1997) Coronary stenting in cardiac allograft vascular disease. Am Heart Journal 134:930-938
28. 28. Kobashigawa JA, Katznelson S, Laks H, Johnson J, Yeatman L, Wang XM, Chia D, Terasaki PI, Sabad A, Cogert GA, Trosian K, Hamilton MA, Moriguchi JD, Kawata M, Hage A, Drinkwater DC, Stevenson LW (1995) Effect of Pravastatin on outcomes after cardiac transplantation. N Engl J Med 333:621-627
29. 29. Wenke K, Meiser B, Thiery J, Nagel D, Scheidt W, Steinbeck G, Seidel D, Reichart B (1997) Simvastatín reduces graft vessel disease and mortality after heart transplantation. Circulation 96:1398-1402
30. 30. Schroeder JS, Gao S-Z, Alderman EL, Hunt SA, Johnstone I, Boothroyd DB, Wiederholt V, Stinson EB (1993) A preliminary study of diltiazem in the prevention of coronary artery disease in heart transplant recipients. N Engl J Med 328:164-170
31. 31. Hojo M, Morimoto T, Maluccio M, Asano T, Morimoto K, Lagman M, Shimbo T, Suthanthiran M (1999) Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 397:530-534
32. 32. Myers BD, Ross J, Newton L, Luescher J, Perlroth M (1984) Cyclosporine-associated chronic nephropathy. N Eng J Med 311: 699-705
33. 33. Hornberger J, Best J, Geppert J, McClellan M (1998) Risks and costs of end stage renal disease after heart transplantation. Transplantation 66:1763-1770